Galenical development of a new sustained-release theophylline pellet formulation for once-daily administration.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Arzneimittel-Forschung

• Publication date

  1988-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 3190808
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nutritional influences on chemical biotransformations in humans.

  2009cited by this paper
• Measurement of theophylline absorption from different regions of the gastro-intestinal tract using a remote controlled durg delivery device

  2004cited by this paper
• Food does not effect in bioavailability of theophylline from Theolin Retard®

  2004cited by this paper
• In vitro — In vivo correlation of dissolution, a time scaling problem? Transformation of in vitro results to the in vivo situation, using theophylline as a practical example

  2004cited by this paper
• Greatly enhanced bioavailability of theophylline on postprandial administration of a sustained release tablet

  2004cited by this paper
• Food reduces the rate but not the extent of the absorption of theophylline from an aqueous solution

  2004cited by this paper
• Feasibility of in-vitro/in-vivo correlation in the case of a new sustained-release theophylline pellet formulation.

  1988cited by this paper
• Validation of the in-vitro dissolution method used for a new sustained-release theophylline pellet formulation.

  1988cited by this paper
• A novel approach to the specification of in-vitro dissolution boundaries based on regulatory requirements for bioequivalence.

  1988cited by this paper
• Once daily theophylline: multiple-dose comparison of an encapsulated micro-osmotic system (Euphylong) with a tablet (Uniphyllin).

  1986cited by this paper
• Transit of pharmaceutical dosage forms through the small intestine.

  1986cited by this paper
• Effect of food on bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms: Part I.

  1986cited by this paper
• Food‐induced changes in theophylline absorption from controlled‐release formulations. Part II. Importance of meal composition and dosing time relative to meal intake in assessing changes in absorption

  1985cited by this paper
• Inconsistent absorption from a sustained-release theophylline preparation during continuous therapy in asthmatic children.

  1985cited by this paper
• Nocturnal asthma: effect of a once per evening dose of sustained release theophylline.

  1985cited by this paper
• Food‐induced changes in theophylline absorption from controlled‐release formulations. Part I. Substantial increased and decreased absorption with Uniphyl tablets and Theo‐Dur Sprinkle

  1985cited by this paper
• Food and a sustained release theophylline tablet on chronic dosing: bioavailability, peak-trough and trough-trough differences

  1985cited by this paper
• Influence of food on the rate and extent of absorption of theophylline after single dose oral administration of a controlled release tablet.

  1985cited by this paper
• Food-induced "dose-dumping" from a once-a-day theophylline product as a cause of theophylline toxicity.

  1985cited by this paper
• Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosing.

  1984cited by this paper
• Erratic absorption of a slow-release theophylline sprinkle product.

  1984cited by this paper
• Pharmacokinetic Drug Interactions with Theophylline

  1984cited by this paper
• Interactions Affecting Drug Absorption

  1984cited by this paper
• Absorption of theophylline from enteric coated and sustained release formulations in fasted and non-fasted subjects.

  1983cited by this paper
• The effect of diet upon serum concentrations of theophylline.

  1983cited by this paper
• Effect of Food on the Bioavailability and Pattern of Release of a Sustained‐Release Theophylline Tablet

  1982cited by this paper
• Single-dose slow-release aminophylline at night prevents nocturnal asthma.

  1982cited by this paper
• Delay in the absorption rate of theophylline from a sustained release theophylline preparation caused by food.

  1981cited by this paper
• Effect of dietary protein and carbohydrate on theophylline metabolism in children.

  1980cited by this paper
• Influence of food on the absorption of acetylsalicylic acid from enteric-coated dosage forms

  1978cited by this paper
• Influence of Food on the Bioavailability of Drugs

  1978cited by this paper
• Mathematical basis of point-area deconvolution method for determining in vivo input functions.

  1978cited by this paper
• Influence of food and diet on gastrointestinal drug absorption: A review

  1977cited by this paper
• Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man

  1976cited by this paper
• Influence of diet and fluid on bioavailability of theophylline

  1975cited by this paper
• Elementary osmotic pump.

  1975cited by this paper

• Perspectives of in vitro dissolution tests in establishing in vivo/in vitro correlations

  2011cites this paper
• Entwicklung von retardierend-umhüllten Pellets

  2003cites this paper
• Relating in vitro/in vivo data of two controlled-release metformin formulations.

  1999cites this paper
• Nonlinear in vitro-in vivo correlations.

  1997cites this paper
• In Vitro-in Vivo Correlations

  1997cites this paper
• Release of drugs from ethyl cellulose microcapsules (diffusion pellets) with pore formers and pore fusion

  1995cites this paper
• Drug release behavior in gastrointestinal tract of beagle dogs from multiple unit type rate-controlled or time-controlled release preparations coated with insoluble polymer-based film

  1995cites this paper
• In Vitro-in Vivo Correlations — Quo Vadis

  1995cites this paper
• Novel Oral Drug Formulations

  1994cites this paper
• International Harmonization of Regulatory Bioequivalence Requirements

  1993cites this paper
• In Vivo/in Vitro Correlation of Experimental Sustained-Release Theophylline Formulations

  1993cites this paper
• Presentation of results from bioequivalence studies.

  1992cites this paper
• Striving for standards in bioequivalence assessment: a review.

  1992cites this paper
• Investigations into the relative bioavailability of carbamazepine after single oral administration of three test batches of a carbamazepine-containing sustained release formulation in healthy subjects.

  1992cites this paper
• Presentation of results from bioequivalence studies.

  1992cites this paper
• Controversies in Bioequivalence Studies

  1992cites this paper
• Striving for standards in bioequivalence assessment: a review.

  1991cites this paper
• Twenty-four hour lung function in adult patients with asthma. Chronoptimized theophylline therapy once-daily dosing in the evening versus conventional twice-daily dosing.

  1990cites this paper
• Pharmacokinetic profile of a new sustained-release theophylline pellet formulation for once-daily evening administration.

  1988cites this paper
• Validation of the in-vitro dissolution method used for a new sustained-release theophylline pellet formulation.

  1988cites this paper
• A novel approach to the specification of in-vitro dissolution boundaries based on regulatory requirements for bioequivalence.

  1988cites this paper
• Feasibility of in-vitro/in-vivo correlation in the case of a new sustained-release theophylline pellet formulation.

  1988cites this paper
• Validation of the pellet coating process used for a new sustained-release theophylline formulation.

  1988cites this paper